Tenet Healthcare (NYSE: THC) director Roy Blunt granted 1,188 RSUs as equity award
Rhea-AI Filing Summary
Blunt Roy reported acquisition or exercise transactions in this Form 4 filing.
Tenet Healthcare director Roy Blunt received a grant of 1,188 restricted stock units as compensation. These 2026 May Restricted Stock Units were awarded at a price of $0.00 per unit and are economically equivalent to 1,188 shares of Tenet common stock.
The units vest on the first anniversary of the grant date, so they are scheduled to vest on May 27, 2027, if service-based conditions are met. After this grant, Blunt holds 1,188 restricted stock units directly. He may elect to receive up to 37% of these vested units in cash instead of shares, which gives some flexibility in how the award is settled.
Positive
- None.
Negative
- None.
Insights
Routine director RSU grant; no open-market buying or selling.
This filing shows director Roy Blunt received 1,188 restricted stock units under Tenet Healthcare’s stock incentive plan. Code A indicates a grant/award, not a market transaction, and the transaction price is listed as $0.00 per unit.
The RSUs vest on May 27, 2027, functioning as time-based compensation to align director interests with shareholders. Each RSU equals one common share economically, but up to 37% may be settled in cash at the director’s election, which slightly reduces direct share issuance.
There are no sales, option exercises, or tax-withholding dispositions in this report. From an investor perspective, this is a standard governance and compensation event, with a modest equity-based award and limited immediate impact on Tenet’s share count.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | 2026 May Restricted Stock Units | 1,188 | $0.00 | -- |
Footnotes (1)
- [object Object]